The role of plasma renin activity, age, and race in selecting effective initial drug therapy for hypertension

American Journal of Hypertension

Volumn 26, Issue 8, 2013, Pages 957-964

  Schwartz, Gary L ^a   Bailey, Kent ^a   Chapman, Arlene B ^b   Boerwinkle, Eric ^c   Turner, Stephen T ^a  

^a MAYO CLINIC   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Blood pressure; Control rate; Hypertension; Pharmacotherapy

Indexed keywords

CANDESARTAN; HYDROCHLOROTHIAZIDE; RENIN;

ADULT; AFRICAN AMERICAN; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; DIASTOLIC BLOOD PRESSURE; DIURETIC THERAPY; DRUG RESPONSE; EUROPEAN AMERICAN; FEMALE; GROUPS BY AGE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; CONTROL RATE; HYPERTENSION; PHARMACOTHERAPY.;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; RENIN; RETROSPECTIVE STUDIES; SODIUM CHLORIDE SYMPORTER INHIBITORS; TETRAZOLES; TREATMENT OUTCOME;

EID: 84881658545     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt047     Document Type: Article

References (20)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT Jr., Roccella EJ; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
2. Bidivilli J, Nussberger J, Waeber G, Porchet M, Waeber B, Brunner HR. Individual responses to converting enzyme inhibitors and calcium antagonists. Hypertension 1988; 11:166-173.
3. Turner, ST, Schwartz GL, Chapman AB, Hall WD, Boerwinkle E. Antihypertensive pharmacogenetics: getting the right drug into the right patient. J Hypertens 2001; 19:1-11.
4. van Brummelen P, Man in't Veld AJ, Schalekamp MA. Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders. Clin Pharmacol Ther 1980; 27:328-336.
5. Guyton AC, Hall JE, Lohmeier TE, Jackson TE, Kastner PR. Blood pressure regulation: basic concepts. Fed Proc 1981; 40:2252-2256.
6. Duprez DA. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation. A clinical review. J Hypertens 2006; 24:983-991.
7. Kaplan NM. Renin profiles. The unfilled promises. JAMA 1977; 238:611-613.
8. Laragh JH, Sealey JE. Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT. Am J Hypertens. 2003; 16:407-415.
9. Laragh JH, Sealey JE. The plasma renin test reveals the contribution of body sodium-volume (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure. Am J Hypertens 2011; 24: 1164-1180.
10. Preston RA, Materson BJ, Reda DJ, Williams DW, Hamburger RJ, Cushman WC, Anderson RJ. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. JAMA 1998; 280:1168-1172.
11. Williams B, Poulter NR, Brown MJ, Davis M, MicInnes GT, Potter JF, Sever PS, McG Thom S. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328:634-640.
12. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. C825T polymorphism of the G protein β3-subunit and antihypertensive response to a thiazide diuretic. Hypertension 2001; 37:739-743.
13. Canzanello VJ, Baranco-Pryor E, Rahbari-Oskoui F, Schwartz GL, Boerwinkle E, Turner ST, Chapman AB. Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension. Am J Hypertens 2008; 21:61-66.
14. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response. JAMA 1982; 248:1996-2003.
15. Moser M, Lunn J. Responses to captopril and hydrochlorothiazide in black patients with hypertension. Clin Pharmacol Ther 1982; 32:307-312.
16. Under T, Gohlke P. Tissue rennin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors. J Am Coll Card 1990; 65:3-10.
17. Preston RA, Materson BJ, Reda DJ, Williams DW, Hamburger RJ, Cushman WC, Anderson RJ. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. JAMA 1998; 280:1168-1172.
18. Materson BJ, Reda DJ, Cushman WC; for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Singledrug therapy for hypertension in men -a comparison of six antihypertensive agents with placebo. N Engl J Med 1993; 328:914-921.
19. Materson BJ, Reda DJ. Correction: single-drug therapy for hypertension in men. N Engl J Med 1994; 330:1689.
20. Materson BJ, Reda DJ, Cushman WC; for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Department of Veterans Affairs single-drug therapy of hypertension study: revised figures and new data. Am J Hypertens 1995; 8: 189-192.